Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Down 47.9% in March

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 541,500 shares, a decline of 47.9% from the February 28th total of 1,039,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 5,415.0 days. Currently, 0.3% of the company’s stock are sold short.

Recordati Industria Chimica e Farmaceutica Price Performance

OTCMKTS RCDTF remained flat at $55.54 during mid-day trading on Friday. The company’s fifty day simple moving average is $55.54 and its two-hundred day simple moving average is $53.69. Recordati Industria Chimica e Farmaceutica has a 52 week low of $52.25 and a 52 week high of $52.25. The stock has a market capitalization of $11.46 billion, a price-to-earnings ratio of 27.77 and a beta of 0.30.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.